Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms
about
A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.Structure of the EMAPII domain of human aminoacyl-tRNA synthetase complex reveals evolutionary dimer mimicryRegulation of endothelial monocyte-activating polypeptide II release by apoptosisStructure-specific tRNA-binding protein from the extreme thermophile Aquifex aeolicusLung self-assembly is modulated by tissue surface tensionsFunctional expansion of human tRNA synthetases achieved by structural inventionstRNA synthetase: tRNA aminoacylation and beyondCell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide IITrbp111 selectively binds a noncovalently assembled tRNA-like structure.A recurrent general RNA binding domain appended to plant methionyl-tRNA synthetase acts as a cis-acting cofactor for aminoacylationVascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesisLung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in miceThe N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.Aminoacyl-tRNA synthetase complexes in evolution.Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understandingControl of stromal keratitis by inhibition of neovascularizationImmunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.Alternative splicing creates two new architectures for human tyrosyl-tRNA synthetaseEndothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.Cellular and molecular basis of tooth eruptionExpression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.Leukocyte migratory responses to apoptosis: the attraction and the distraction.A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro.EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.Tumour vasculature--a potential therapeutic target.Regulation of EMAP II by hypoxia.FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.
P2860
Q24292091-AE0AA751-61D0-44F1-957A-4C82D1DD7319Q24536732-E801FE94-6A36-41CF-99FD-D05604DFFE7BQ28369078-C7D2DFF7-AF44-4E2B-9BD4-9D10F9D0FE2EQ28769585-9A64B28B-C90B-47E6-8F44-8CF2A9F70A86Q30500267-98E4AF85-51D8-4C4E-8D71-DE0B347C87E4Q33677123-A150C7B2-2088-410E-B6AD-9DC0F5DC991BQ33774299-7D1BE3A8-D292-4284-AB89-B8B735F42F5CQ34193685-C4A8CBAF-8676-4DBD-A9C6-5E45D3E457DCQ34429359-8906EEC6-2228-4729-B58E-009A23AE06B9Q34683911-58BB858A-8B16-4B00-B1C4-3FE2C6CA5982Q34789755-0CA589DF-538C-4024-8E12-E297E5695418Q34995850-4DDDC6EB-1FEA-4D03-B5A0-06A78B54423EQ35015668-76FA5791-D3E5-40EE-AA0E-DB4E8A1844A0Q35351996-4B4B2F88-F4E7-4362-94EF-3320EC83640BQ35381830-C1B0F1AE-8D4D-4705-90EC-69CC1FF40E14Q35652150-BF93692E-BCE6-4600-B30F-AADE9FE7E392Q35746765-25FE94AD-5821-4997-965B-8A7224FD1C9AQ35829757-C94DA31C-26F1-444A-9027-1D7487F6D8B3Q35895697-E59875BD-7477-4393-BDE1-8DD67FDACA75Q36375147-6D451B87-FF83-4740-AA66-41EB6EC14D95Q37038009-B4880F89-80A8-4B33-9592-44D8D7486ECCQ37354891-485B2CFE-51EA-48EE-B6AF-384EA8D2DF3DQ37472189-22EEA06E-017C-4461-94D2-01059CA08D00Q38288255-5A94CD23-9982-45A6-BF45-565087382654Q38975996-4CACAC43-54CC-469A-8B5B-E14C48ED1B66Q39812178-508CAFB8-0A92-4207-BDED-2E1761B99F1BQ40240186-8770E418-4A42-4F50-A353-CD440610E6FAQ40403280-E46E5493-7206-4066-91D0-309755B04BD6Q42004172-2F9C51EC-B002-4146-A1FC-B444129ADA43Q42076881-93699523-7595-4B6F-8E48-0F2B7F956612Q42148044-D54C15AC-229C-4364-8084-21D639255947
P2860
Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Endothelial monocyte-activatin ...... vates host-response mechanisms
@ast
Endothelial monocyte-activatin ...... vates host-response mechanisms
@en
Endothelial monocyte-activatin ...... vates host-response mechanisms
@nl
type
label
Endothelial monocyte-activatin ...... vates host-response mechanisms
@ast
Endothelial monocyte-activatin ...... vates host-response mechanisms
@en
Endothelial monocyte-activatin ...... vates host-response mechanisms
@nl
prefLabel
Endothelial monocyte-activatin ...... vates host-response mechanisms
@ast
Endothelial monocyte-activatin ...... vates host-response mechanisms
@en
Endothelial monocyte-activatin ...... vates host-response mechanisms
@nl
P2093
P1476
Endothelial monocyte-activatin ...... vates host-response mechanisms
@en
P2093
Familletti PC
P304
20239-20247
P407
P577
1992-10-01T00:00:00Z